Metronomic Chemotherapy: Hope or Hype

RACE-approved free webinar sponsored by Epicure Pharma. 

Speaker: Craig A Clifford DVM, MS, DACVIM (Oncology)

Learning objectives:

1. Review of metronomic therapy and its mechanism of action

2. Review of the literature supporting and refuting its use

3. Concerns over compounding (not all are created equal)

4. Where we see metronomic therapy being used in veterinary oncology

Overview:

Metronomic therapy involves the use of ultralow dosing of chemotherapeutics. We will discuss the various mechanisms of action behind this type of therapy and where the literature supports its use. We will cover how to monitor and concerns that can arise even with such low dosing. Last we will discuss what to ask for in a compounder as all are not created equal!